Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)
This study is currently recruiting participants.
Verified April 2013 by Indiana University
Sponsor:
Indiana University School of Medicine
Information provided by (Responsible Party):
Indiana University ( Indiana University School of Medicine )
ClinicalTrials.gov Identifier:
NCT00198081
First received: September 12, 2005
Last updated: April 1, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | September 2021 |
| Estimated Primary Completion Date: | September 2020 (Final data collection date for primary outcome measure) |